← Eichor
Condition: Thyroid Associated Orbitopathy Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Thyroid Associated Orbitopathy

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Extension Study of Two Doses of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED)
Phase 2/Phase 3 · 2 location(s) · Sling Therapeutics, Inc. · NCT06112340Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
Phase 2 · 1 location(s) · Haukeland University Hospital · NCT04936854A Study on the Combined Use of Tocilizumab and Flupentixol-Melitracen in the Treatment of Thyroid-Associated Ophthalmopa
Phase 4 · 1 location(s) · Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao · NCT06927375Treatment of Graves´ophthalmopathy with Simvastatin (GO-S)
Phase 3 · 1 location(s) · Lund University · NCT03131726
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.